Supernus Pharmaceuticals (SUPN)

6.285 +0.03  +0.40%  May 21, 5:00PM
Add to Watchlists Create an Alert

Supernus Pharmaceuticals EBITDA TTM

View Full Chart

Supernus Pharmaceuticals EBITDA TTM Chart

View EBITDA TTM for SUPN.
Start Your YCharts Pro Gold Membership.

Supernus Pharmaceuticals Historical EBITDA TTM Data

Pro Data Export
Dates:  to
Viewing 1 of 1   First  Previous First    Next  Last   Last

There is no data for the selected date range.

Data for this Date Range  
Dec. 31, 2012 Go Pro
Sept. 30, 2012 Go Pro
June 30, 2012 Go Pro
   
March 31, 2012 Go Pro
Dec. 31, 2011 Go Pro
Sept. 30, 2011 Go Pro

About EBITDA (TTM)

EBITDA is an abbreviation for earnings before interest, taxes, depreciation, and amortization. EBITDA (TTM) is the sum of the last four quarters of EBITDA.

Investors often use EBITDA as a starting point for discounted cash flow analysis or to observe the performance of a business separately from its capital structure (debt vs equity financing structure).

Though EBITDA does form an excellent basis for cash flow analysis, some investors argue that it is a misleading measure since depreciation expenses are a real cost - old property, plant and equipment must eventually be replaced if a business plans to continue operations using those assets.
Learn More

View EBITDA TTM for SUPN.
Start Your YCharts Pro Gold Membership.

Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle.

YCharts Pro is only $49/month, and comes with a 14-day free trial.

Get Started Now

Already a YCharts Pro Gold Member? Sign in here.